Perspectives & Progress

T.Rx Capital Launches $77.5M Fund I to Invest in Bold Startups at the Intersection of Technology and Biology

New venture capital firm to create and invest in early-stage healthcare companies applying novel technologies to frontier biology and redefine patient care

Recuro Health Closes $47 Million Series B Financing Led by ARCH  Venture  Partners, Advancing Virtual‑First Care

Recuro Health, a Dallas-based digital health startup, raised $47 M to scale its Digital Medical Home—including virtual primary & behavioral care, at-home diagnostics, and genomics—with support from ARCH Venture Partners and others.

Zus Health Closes Financing, Signs Partnership with Elation Health to Accelerate Growth of Its Data Service

Health‑IT platform ‘connecting the connective tissue for healthcare’ closes a $40 M financing round and partners with Elation Health to integrate its ZAP aggregated patient profile into primary‑care EHR workflows.

They said I should give up, but I don’t like to give up”: How Robert Langer failed repeatedly—and kept going

A trailblazing MIT professor and co‑founder of Moderna who pioneered nanoparticle delivery of nucleic acids. Despite early skepticism and patent rejections, his persistence led to breakthroughs foundational for mRNA vaccines.

Ready to Transform Healthcare?

Join us in building the future of medicine through innovative technology and biology convergence